BioCentury | Jun 5, 2013
Financial News

Sosei targeting $19.9M regenerative medicine fund

Sosei Group Corp. (Tokyo:4565) said it is targeting to raise an initial Y2 billion ($19.9 million) by the end of September for its Regenerative Medicine Fund 1 (RMF1). The fund will invest primarily in Japanese...
BioCentury | Apr 21, 2011
Financial News

Aduro targets $19.3M in series B

Cancer company Aduro BioTech (Berkeley, Calif.) raised an undisclosed amount in the first tranche of a planned $19.3 million series B round. The tranche was led by new investor Morningside Ventures, with participation from existing...
BioCentury | Jan 3, 2005
Tools & Techniques

Better beta cell activator

Arena Pharmaceuticals Inc. says its small molecule 19AJ receptor agonists to treat Type II diabetes exploit a new mechanism of action to activate pancreatic islet beta cells to secrete insulin, without the risk of hypoglycemia...
Items per page:
1 - 3 of 3